Visual Performance of the Vivity IOL in Post-myopic LASIK and PRK Patients

Sponsor
Laser & Corneal Surgery Associates (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05961046
Collaborator
Sengi (Industry)
40
2
12
20
1.7

Study Details

Study Description

Brief Summary

The objective is to evaluate visual outcomes and patient satisfaction in patients with a history of myopic LASIK or PRK who will have completed cataract surgery with the Vivity IOL.

Condition or Disease Intervention/Treatment Phase
  • Device: Vivity IOL

Detailed Description

This study Prospective, non-interventional, single-center, single-surgeon, single-arm observational study of visual outcomes and patient satisfaction in patients with a history of myopic LASIK or PRK who will have completed cataract surgery with the Vivity IOL. Subjects will be assessed at least 3 months postoperatively. Clinical evaluations will include administration of a satisfaction questionnaire (IOLSAT), as well as measurement of binocular and monocular visual acuities, defocus curve, and manifest refraction.

Study Design

Study Type:
Observational
Anticipated Enrollment :
40 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Visual Performance of the Vivity IOL in Post-myopic LASIK and PRK Patients
Anticipated Study Start Date :
Jul 17, 2023
Anticipated Primary Completion Date :
Jul 17, 2024
Anticipated Study Completion Date :
Jul 17, 2024

Arms and Interventions

Arm Intervention/Treatment
1

Patients with a history of successful myopic LASIK/PRK and underwent bilateral uncomplicated cataract surgery with non-toric Alcon Vivity IOL

Device: Vivity IOL
Vivity IOL

Outcome Measures

Primary Outcome Measures

  1. Binocular corrected distance visual acuity [3 months after surgery]

Secondary Outcome Measures

  1. Monocular uncorrected visual acuity [3 months after surgery]

    At distance, intermediate, and near

  2. Monocular corrected visual acuity [3 months after surgery]

    At distance, intermediate, and near

  3. Binocular corrected visual acuity [3 months after surgery]

    At intermediate and near

  4. Binocular uncorrected visual acuity [3 months after surgery]

    At distance, intermediate, and near

  5. Binocular Defocus curve [3 months after surgery]

  6. Satisfaction Questionnaire [3 months after surgery]

    The Intraocular Lens Satisfaction questionnaire (IOLSAT). Lower scores indicate higher spectacle independence and satisfaction.

  7. Visual Disturbance Questionnaire [3 months after surgery]

    Lower scores indicate less severe visual disturbances.

  8. Refractive Outcomes [3 months after surgery]

    Manifest refraction spherical equivalent (MRSE), residual sphere, astigmatism

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Subjects are eligible for the study if they meet the following criteria:

Note: Ocular criteria must be met in both eyes.

  • Adult (at least 40 years) patients with a history of successful myopic LASIK/PRK and underwent bilateral uncomplicated cataract surgery with non-toric Alcon Vivity IOL at least 3 months before enrollment.

  • Monocular BCDVA 20/25 or better.

  • Patients may be >2 weeks post-YAG capsulotomy for visually significant PCO.

  • Post-operative sphere ≤0.50D, astigmatism ≤0.50D, and MRSE < 0.75D.

Exclusion Criteria:

If any of the following exclusion criteria are applicable to the subject or either eye, the subject should not be enrolled in the study.

  • Patients with corneal refractive surgery complications, significant ocular pathology, including moderate and severe dry eye, retina, optic nerve (including glaucoma) and corneal pathologies (e.g. corneal dystrophy, edema, significant scarring), limiting or affecting visual potential, in the opinion of the surgeon.

  • Patients undergoing cataract removal with MIGS procedure.

  • Patients with h/o ocular surgery, other than corneal refractive surgery, that may limit or affect visual potential in the opinion of the surgeon.

The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.

Pregnancy has a known effect on the stability of refractions and visual acuity. As such, subjects who become pregnant during the study will not be discontinued but their data may be excluded from analyses of effectiveness.

Contacts and Locations

Locations

Site City State Country Postal Code
1 LCSA Manhattan New York New York United States 10016
2 LCSA White Plains White Plains New York United States 10605

Sponsors and Collaborators

  • Laser & Corneal Surgery Associates
  • Sengi

Investigators

  • Principal Investigator: Jimmy Y Hu, MD, Laser and Corneal Surgery Associates

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Laser & Corneal Surgery Associates
ClinicalTrials.gov Identifier:
NCT05961046
Other Study ID Numbers:
  • JH-23-01
First Posted:
Jul 27, 2023
Last Update Posted:
Jul 27, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2023